Summary
Latest filing:
Krishna Yeshwant files SEC Form 4 reports at Parabilis Medicines, Inc. (PBLS). 2 SEC Form 4 filings on record going back to 2025, most recently on 11 June 2026.
Recent transactions
3The latest 3 SEC Form 4 transactions reported by Krishna Yeshwant.
Trading pattern
InsiderAlpha's records for Krishna Yeshwant go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Krishna Yeshwant files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Guy Levy - $10.00M in PBLS purchases and sales in the last 12 months
- Alan Sebulsky - $724K in PBLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Krishna Yeshwant?
Krishna Yeshwant is a corporate insider of Parabilis Medicines, Inc. (PBLS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Krishna Yeshwant last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 2 filings going back to 2025.